Cibc Private Wealth Group, LLC Chembio Diagnostics, Inc. Transaction History

Cibc Private Wealth Group, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 05, 2019	SELL	$4.95 - $10.5 $143,550 - $304,500	-29,000 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$5.95 - $8.35 $172,550 - $242,150	29,000	29,000 $238,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.